H.R. 7189, Congenital Heart Futures Reauthorization Act of 2024
As reported by the House Committee on Energy and Commerce on May 22, 2024
By Fiscal Year, Millions of Dollars
2024
2024-2029
2024-2034
Direct Spending (Outlays)
0
0
0
Revenues
0
0
0
Increase or Decrease (-) in the Deficit
0
0
0
Spending Subject to Appropriation (Outlays)
0
43
50
Increases net direct spending in any of the four consecutive 10-year periods beginning in 2035?
No
Statutory pay-as-you-go procedures apply?
No
Mandate Effects
Increases on-budget deficits in any of the four consecutive 10-year periods beginning in 2035?
No
Contains intergovernmental mandate?
No
Contains private-sector mandate?
No
Summary
H.R. 7189 would reauthorize the appropriation of $10 million each year from 2025 through 2029 for the Department of Health and Human Services (HHS) to carry out research, surveillance, and awareness activities on congenital heart disease. The bill also would require HHS to report to the Congress on its current activities related to congenital heart disease and a strategy for improving efforts to raise public awareness and train health care professionals in that area. In 2024, the Congress appropriated $8 million for those activities.
Based on historical spending patterns for those activities and assuming the appropriation of the authorized amounts, CBO estimates that implementing the bill would cost $43 million over the 2024-2029 period and $7 million after 2029.
